ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells

Cite this: J. Med. Chem. 1995, 38, 16, 3146–3155
Publication Date (Print):August 1, 1995
https://doi.org/10.1021/jm00016a018
Copyright © 1995 American Chemical Society
    ACS Legacy Archive

    Article Views

    1417

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 273 publications.

    1. Max Lewandowski, Melania Carmina, Loris Knümann, Minh Sai, Sabine Willems, Till Kasch, Julius Pollinger, Stefan Knapp, Julian A. Marschner, Apirat Chaikuad, Daniel Merk. Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties. Journal of Medicinal Chemistry 2024, 67 (3) , 2152-2164. https://doi.org/10.1021/acs.jmedchem.3c02095
    2. Gustave Adouvi, Felix Nawa, Marco Ballarotto, Lorena Andrea Rüger, Loris Knümann, Till Kasch, Silvia Arifi, Manfred Schubert-Zsilavecz, Sabine Willems, Julian A. Marschner, Jörg Pabel, Daniel Merk. Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry 2023, 66 (24) , 16762-16771. https://doi.org/10.1021/acs.jmedchem.3c01435
    3. Gustave Adouvi, Laura Isigkeit, Úrsula López-García, Apirat Chaikuad, Julian A. Marschner, Manfred Schubert-Zsilavecz, Daniel Merk. Rational Design of a New RXR Agonist Scaffold Enabling Single-Subtype Preference for RXRα, RXRβ, and RXRγ. Journal of Medicinal Chemistry 2023, 66 (1) , 333-344. https://doi.org/10.1021/acs.jmedchem.2c01266
    4. Sabine Willems, Daniel Zaienne, Daniel Merk. Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation. Journal of Medicinal Chemistry 2021, 64 (14) , 9592-9638. https://doi.org/10.1021/acs.jmedchem.1c00186
    5. Sanchita Mallick, Pamela A. Marshall, Carl E. Wagner, Michael C. Heck, Zhela L. Sabir, Marya S. Sabir, Christoper M. Dussik, Aleksandra Grozic, Ichiro Kaneko, Peter W. Jurutka. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells. ACS Chemical Neuroscience 2021, 12 (5) , 857-871. https://doi.org/10.1021/acschemneuro.0c00707
    6. Julius Pollinger, Leonie Gellrich, Simone Schierle, Whitney Kilu, Jurema Schmidt, Lena Kalinowsky, Julia Ohrndorf, Astrid Kaiser, Jan Heering, Ewgenij Proschak, Daniel Merk. Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. Journal of Medicinal Chemistry 2019, 62 (4) , 2112-2126. https://doi.org/10.1021/acs.jmedchem.8b01848
    7. Tanaji T. Talele. Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry. Journal of Medicinal Chemistry 2018, 61 (6) , 2166-2210. https://doi.org/10.1021/acs.jmedchem.7b00315
    8. Michael D. Rush, Elisabeth M. Walker, Gerd Prehna, Tristesse Burton, Richard B. van Breemen. Development of a Magnetic Microbead Affinity Selection Screen (MagMASS) Using Mass Spectrometry for Ligands to the Retinoid X Receptor-α. Journal of the American Society for Mass Spectrometry 2017, 28 (3) , 479-485. https://doi.org/10.1007/s13361-016-1564-0
    9. Michael C. Heck, Carl E. Wagner, Pritika H. Shahani, Mairi MacNeill, Aleksandra Grozic, Tamana Darwaiz, Micah Shimabuku, David G. Deans, Nathan M. Robinson, Samer H. Salama, Joseph W. Ziller, Ning Ma, Arjan van der Vaart, Pamela A. Marshall, and Peter W. Jurutka . Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN). Journal of Medicinal Chemistry 2016, 59 (19) , 8924-8940. https://doi.org/10.1021/acs.jmedchem.6b00812
    10. Amelia H. Baker, James Watt, Cassie K. Huang, Louis C. Gerstenfeld, and Jennifer J. Schlezinger . Tributyltin Engages Multiple Nuclear Receptor Pathways and Suppresses Osteogenesis in Bone Marrow Multipotent Stromal Cells. Chemical Research in Toxicology 2015, 28 (6) , 1156-1166. https://doi.org/10.1021/tx500433r
    11. Fengzhi Zhang, Shoubhik Das, Andrew J. Walkinshaw, Alicia Casitas, Michael Taylor, Marcos G. Suero, and Matthew J. Gaunt . Cu-Catalyzed Cascades to Carbocycles: Union of Diaryliodonium Salts with Alkenes or Alkynes Exploiting Remote Carbocations. Journal of the American Chemical Society 2014, 136 (25) , 8851-8854. https://doi.org/10.1021/ja504361y
    12. Rosana Álvarez, Belén Vaz, Hinrich Gronemeyer, and Ángel R. de Lera . Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids. Chemical Reviews 2014, 114 (1) , 1-125. https://doi.org/10.1021/cr400126u
    13. Peter W. Jurutka, Ichiro Kaneko, Joanna Yang, Jaskaran S. Bhogal, Johnathon C. Swierski, Christa R. Tabacaru, Luis A. Montano, Chanh C. Huynh, Rabia A. Jama, Ryan D. Mahelona, Joseph T. Sarnowski, Lisa M. Marcus, Alexis Quezada, Brittney Lemming, Maria A. Tedesco, Audra J. Fischer, Said A. Mohamed, Joseph W. Ziller, Ning Ma, Geoffrey M. Gray, Arjan van der Vaart, Pamela A. Marshall, and Carl E. Wagner . Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic Acid (CD3254). Journal of Medicinal Chemistry 2013, 56 (21) , 8432-8454. https://doi.org/10.1021/jm4008517
    14. Zebin Xia, Lulu Farhana, Ricardo G. Correa, Jayanta K. Das, David J. Castro, Jinghua Yu, Robert G. Oshima, John C. Reed, Joseph A. Fontana, and Marcia I. Dawson . Heteroatom-Substituted Analogues of Orphan Nuclear Receptor Small Heterodimer Partner Ligand and Apoptosis Inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic Acid. Journal of Medicinal Chemistry 2011, 54 (11) , 3793-3816. https://doi.org/10.1021/jm200051z
    15. Ioannis S. Vizirianakis, Maria Chatzopoulou, Ioannis D. Bonovolias, Ioannis Nicolaou, Vassilis J. Demopoulos, and Asterios S. Tsiftsoglou . Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. Journal of Medicinal Chemistry 2010, 53 (19) , 6779-6810. https://doi.org/10.1021/jm100189a
    16. Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall, Thomas L. Groy, Arjan van der Vaart, Joseph W. Ziller, Julie K. Furmick, Mark E. Graeber, Erik Matro, Belinda V. Miguel, Ivy T. Tran, Jungeun Kwon, Jamie N. Tedeschi, Shahram Moosavi, Amina Danishyar, Joshua S. Philp, Reina O. Khamees, Jevon N. Jackson, Darci K. Grupe, Syed L. Badshah and Justin W. Hart . Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene). Journal of Medicinal Chemistry 2009, 52 (19) , 5950-5966. https://doi.org/10.1021/jm900496b
    17. Dongting Liu,, Jian Guo,, Yan Luo,, David J. Broderick,, Michael I. Schimerlik,, John M. Pezzuto, and, Richard B. van Breemen. Screening for Ligands of Human Retinoid X Receptor-α Using Ultrafiltration Mass Spectrometry. Analytical Chemistry 2007, 79 (24) , 9398-9402. https://doi.org/10.1021/ac701701k
    18. Roberto Pellicciari,, Gabriele Costantino, and, Stefano Fiorucci. Farnesoid X Receptor:  From Structure to Potential Clinical Applications. Journal of Medicinal Chemistry 2005, 48 (17) , 5383-5403. https://doi.org/10.1021/jm0582221
    19. Claudio N. Cavasotto,, Gang Liu,, Sharon Y. James,, Peter D. Hobbs,, Valerie J. Peterson,, Ananyo A. Bhattacharya,, Siva K. Kolluri,, Xiao-kun Zhang,, Mark Leid,, Ruben Abagyan,, Robert C. Liddington, and, Marcia I. Dawson. Determinants of Retinoid X Receptor Transcriptional Antagonism. Journal of Medicinal Chemistry 2004, 47 (18) , 4360-4372. https://doi.org/10.1021/jm030651g
    20. Marcia I. Dawson,, Danni L. Harris,, Gang Liu,, Peter D. Hobbs,, Christopher W. Lange,, Ling Jong,, Nathalie Bruey-Sedano,, Sharon Y. James,, Xiao-kun Zhang,, Valerie J. Peterson,, Mark Leid,, Lulu Farhana,, Arun K. Rishi, and, Joseph A. Fontana. Antagonist Analogue of 6-[3‘-(1-Adamantyl)-4‘-hydroxyphenyl]-2-naphthalenecarboxylic Acid (AHPN) Family of Apoptosis Inducers That Effectively Blocks AHPN-Induced Apoptosis but Not Cell-Cycle Arrest. Journal of Medicinal Chemistry 2004, 47 (14) , 3518-3536. https://doi.org/10.1021/jm030524k
    21. Curt D. Haffner,, James M. Lenhard,, Aaron B. Miller,, Darryl L. McDougald,, Kate Dwornik,, Olivia R. Ittoop,, Robert T. Gampe, Jr.,, H. Eric Xu,, Steve Blanchard,, Valerie G. Montana,, Tom G. Consler,, Randy K. Bledsoe,, Andrea Ayscue, and, Dallas Croom. Structure-Based Design of Potent Retinoid X Receptor α Agonists. Journal of Medicinal Chemistry 2004, 47 (8) , 2010-2029. https://doi.org/10.1021/jm030565g
    22. Pierre-Yves Michellys,, Robert J. Ardecky,, Jyun-Hung Chen,, Jennifer D'Arrigo,, Timothy A. Grese,, Donald S. Karanewsky,, Mark D. Leibowitz,, Sha Liu,, Dale A. Mais,, Christopher M. Mapes,, Chahrzad Montrose-Rafizadeh,, Katheen M. Ogilvie, Anne Reifel-Miller,, Deepa Rungta,, Anthony W. Thompson,, John S. Tyhonas, and, Marcus F. Boehm. Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids. Journal of Medicinal Chemistry 2003, 46 (19) , 4087-4103. https://doi.org/10.1021/jm020401k
    23. P. Y. Michellys , R. J. Ardecky , J. H. Chen , D. L. Crombie , G. J. Etgen , A. L. Faulkner , M. M. Faul , T. A. Grese , R. A. Heyman , D. S. Karanewsky , K. Klausing , M. D. Leibowitz , S. Liu , D. A. Mais , C. M. Mapes , K. B. Marschke , A. Reifel-Miller , K. M. Ogilvie , D. Rungta , A. W. Thompson , J. S. Tyhonas , and M. F. Boehm . Novel (2E,4E,6Z)-7-(2-Alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic Acid Retinoid X Receptor Modulators Are Active in Models of Type 2 Diabetes. Journal of Medicinal Chemistry 2003, 46 (13) , 2683-2696. https://doi.org/10.1021/jm020340q
    24. Yolanda Pazos,, Beatriz Iglesias, and, Angel R. de Lera. The Suzuki Coupling Reaction in the Stereocontrolled Synthesis of 9-cis-Retinoic Acid and Its Ring-Demethylated Analogues,1. The Journal of Organic Chemistry 2001, 66 (25) , 8483-8489. https://doi.org/10.1021/jo010711v
    25. Donald F. Doyle,, Dwaine A. Braasch,, Laurie K. Jackson,, Harald E. Weiss,, Marcus F. Boehm,, David J. Mangelsdorf, and, David R. Corey. Engineering Orthogonal Ligand−Receptor Pairs from “Near Drugs”. Journal of the American Chemical Society 2001, 123 (46) , 11367-11371. https://doi.org/10.1021/ja0164632
    26. Margaret M. Faul,, Andrew M. Ratz,, Kevin A. Sullivan,, William G. Trankle, and, Leonard L. Winneroski. Synthesis of Novel Retinoid X Receptor-Selective Retinoids. The Journal of Organic Chemistry 2001, 66 (17) , 5772-5782. https://doi.org/10.1021/jo0103064
    27. Daniele Simoni,, Marinella Roberti,, Francesco Paolo Invidiata,, Riccardo Rondanin,, Riccardo Baruchello,, Cinzia Malagutti,, Angelica Mazzali,, Marcello Rossi,, Stefania Grimaudo,, Francesca Capone,, Luisa Dusonchet,, Maria Meli,, Maria Valeria Raimondi,, Marilena Landino,, Natale D'Alessandro,, Manlio Tolomeo,, Dhar Arindam,, Shennan Lu, and, Doris M. Benbrook. Heterocycle-Containing Retinoids. Discovery of a Novel Isoxazole Arotinoid Possessing Potent Apoptotic Activity in Multidrug and Drug-Induced Apoptosis-Resistant Cells. Journal of Medicinal Chemistry 2001, 44 (14) , 2308-2318. https://doi.org/10.1021/jm0010320
    28. Vidyasagar Vuligonda,, Scott M. Thacher, and, Roshantha A. S. Chandraratna. Enantioselective Syntheses of Potent Retinoid X Receptor Ligands:  Differential Biological Activities of Individual Antipodes. Journal of Medicinal Chemistry 2001, 44 (14) , 2298-2303. https://doi.org/10.1021/jm0100584
    29. Lawrence G. Hamann. An Efficient, Stereospecific Synthesis of the Dimer-Selective Retinoid X Receptor Modulator (2E,4E,6Z)-7-[5,6,7,8- Tetrahydro-5,5,8,8-tetramethyl-2- (n-propyloxy)naphthalen-3-yl]-3- methylocta-2,4,6-trienoic Acid. The Journal of Organic Chemistry 2000, 65 (10) , 3233-3235. https://doi.org/10.1021/jo991936x
    30. Kouichi Kikuchi,, Shigeki Hibi,, Hiroyuki Yoshimura,, Naoki Tokuhara,, Kenji Tai,, Takayuki Hida,, Toshihiko Yamauchi, and, Mitsuo Nagai. Syntheses and Structure−Activity Relationships of 5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline Derivatives with Retinoic Acid Receptor α Agonistic Activity. Journal of Medicinal Chemistry 2000, 43 (3) , 409-419. https://doi.org/10.1021/jm990063w
    31. Daniele Simoni,, Francesco Paolo Invidiata,, Riccardo Rondanin,, Stefania Grimaudo,, Giuliana Cannizzo,, Eleonora Barbusca,, Ferdinando Porretto,, Nicola D'Alessandro, and, Manlio Tolomeo. Structure−Activity Relationship Studies of Novel Heteroretinoids:  Induction of Apoptosis in the HL-60 Cell Line by a Novel Isoxazole-Containing Heteroretinoid. Journal of Medicinal Chemistry 1999, 42 (24) , 4961-4969. https://doi.org/10.1021/jm991059n
    32. Arindam Dhar,, Shengquan Liu,, Jozef Klucik,, K. Darrell Berlin,, Matora M. Madler,, Shennan Lu,, R. Todd Ivey,, David Zacheis,, Chad W. Brown,, E. C. Nelson,, Paul J. Birckbichler, and, Doris M. Benbrook. Synthesis, Structure−Activity Relationships, and RARγ−Ligand Interactions of Nitrogen Heteroarotinoids. Journal of Medicinal Chemistry 1999, 42 (18) , 3602-3614. https://doi.org/10.1021/jm9900974
    33. Stacie S. Canan Koch,, Laura J. Dardashti,, Rosemary M. Cesario,, Glenn E. Croston,, Marcus F. Boehm,, Richard A. Heyman, and, Alex M. Nadzan. Synthesis of Retinoid X Receptor-Specific Ligands That Are Potent Inducers of Adipogenesis in 3T3-L1 Cells. Journal of Medicinal Chemistry 1999, 42 (4) , 742-750. https://doi.org/10.1021/jm980621r
    34. Shigeki Hibi,, Kouichi Kikuchi,, Hiroyuki Yoshimura,, Mitsuo Nagai,, Kenji Tai, and, Takayuki Hida. Syntheses and Structure−Activity Relationships of Novel Retinoid X Receptor Agonists. Journal of Medicinal Chemistry 1998, 41 (17) , 3245-3252. https://doi.org/10.1021/jm980058c
    35. Paul Jones,, Gérald B. Villeneuve,, Chengpei Fei,, Josie DeMarte,, Allison J. Haggarty,, Khin Than Nwe,, Deborah A. Martin,, Anne-Marie Lebuis,, Joshua M. Finkelstein,, Barbara J. Gour-Salin,, Tak Hang Chan, and, Brian R. Leyland-Jones. Synthesis and Structure−Activity Relationships of 2-Pyrazinylcarboxamido- benzoates and β-Ionylideneacetamidobenzoates with Retinoidal Activity. Journal of Medicinal Chemistry 1998, 41 (16) , 3062-3077. https://doi.org/10.1021/jm9801354
    36. Doris M. Benbrook,, Matora M. Madler,, Lyle W. Spruce,, Paul J. Birckbichler,, Eldon C. Nelson,, Shankar Subramanian,, G. Mahika Weerasekare,, Jonathan B. Gale,, Manford K. Patterson, Jr.,, Binghe Wang,, Wei Wang,, Shennan Lu,, Tami C. Rowland,, Paul DiSivestro,, Charles Lindamood III,, Donald L. Hill, and, K. Darrell Berlin. Biologically Active Heteroarotinoids Exhibiting Anticancer Activity and Decreased Toxicity. Journal of Medicinal Chemistry 1997, 40 (22) , 3567-3583. https://doi.org/10.1021/jm970196m
    37. Stacie S. Canan Koch,, Laura J. Dardashti,, Jonathan J. Hebert,, Steven K. White,, Glenn E. Croston,, Karen S. Flatten,, Richard A. Heyman, and, Alex M. Nadzan. Identification of the First Retinoid X Receptor Homodimer Antagonist. Journal of Medicinal Chemistry 1996, 39 (17) , 3229-3234. https://doi.org/10.1021/jm960311d
    38. Min Teng,, Tien T. Duong,, Elliott S. Klein,, Mary E. Pino, and, Roshantha A. S. Chandraratna. Identification of a Retinoic Acid Receptor α Subtype Specific Agonist. Journal of Medicinal Chemistry 1996, 39 (16) , 3035-3038. https://doi.org/10.1021/jm9603532
    39. Richard L. Beard,, Diana F. Colon,, Tae K. Song,, Peter J. A. Davies,, Devendra M. Kochhar, and, Roshantha A. S. Chandraratna. Synthesis and Structure−Activity Relationships of Retinoid X Receptor Selective Diaryl Sulfide Analogs of Retinoic Acid. Journal of Medicinal Chemistry 1996, 39 (18) , 3556-3563. https://doi.org/10.1021/jm960386h
    40. Youssef L. Bennani. An Efficient and Stereoselective Synthesis of 9-cis-Retinoic Acid. The Journal of Organic Chemistry 1996, 61 (10) , 3542-3544. https://doi.org/10.1021/jo952189g
    41. Olga V. Belyaeva, Alla V. Klyuyeva, Ansh Vyas, Wilhelm K. Berger, Laszlo Halasz, Jianshi Yu, Venkatram R. Atigadda, Aja Slay, Kelli R. Goggans, Matthew B. Renfrow, Maureen A. Kane, Laszlo Nagy, Natalia Y. Kedishvili, . The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid. PLOS ONE 2024, 19 (4) , e0301447. https://doi.org/10.1371/journal.pone.0301447
    42. Hiroya Shiino, Shinya Tashiro, Michiko Hashimoto, Yuki Sakata, Takamitsu Hosoya, Toshiya Endo, Hirotatsu Kojima, Yasushi Tamura. Chemical inhibition of phosphatidylcholine biogenesis reveals its role in mitochondrial division. iScience 2024, 27 (3) , 109189. https://doi.org/10.1016/j.isci.2024.109189
    43. Laura Isigkeit, Annette Kärcher, Gustave Adouvi, Silvia Arifi, Daniel Merk. Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid. ChemMedChem 2024, 19 (5) https://doi.org/10.1002/cmdc.202300379
    44. Christopher F. Stratton, Lawrence M. Szewczuk, Juncai Meng. Off‐Line Affinity Selection Mass Spectrometry and Its Application in Lead Discovery. 2023, 267-296. https://doi.org/10.1002/9781119678496.ch8
    45. Jun Chen, Taige Zhao, Fengming He, Yijing Zhong, Susu Wang, Ziqing Tang, Yingkun Qiu, Zhen Wu, Meijuan Fang. Discovery of bipyridine amide derivatives targeting pRXRα-PLK1 interaction for anticancer therapy. European Journal of Medicinal Chemistry 2023, 254 , 115341. https://doi.org/10.1016/j.ejmech.2023.115341
    46. Harald Carlsen, Kanae Ebihara, Nobuyo H. Kuwata, Kazuhisa Kuwata, Gamze Aydemir, Ralph Rühl, Rune Blomhoff. A transgenic reporter mouse model for in vivo assessment of retinoic acid receptor transcriptional activation. International Journal for Vitamin and Nutrition Research 2023, 93 (1) , 29-41. https://doi.org/10.1024/0300-9831/a000705
    47. Nahid Shahabadi, Saba Zendehcheshm, Mohammad Mahdavi, Fatemeh Khademi. Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective. Informatics in Medicine Unlocked 2023, 36 , 101147. https://doi.org/10.1016/j.imu.2022.101147
    48. Peter W. Jurutka, Orsola di Martino, Sabeeha Reshi, Sanchita Mallick, Michael A. Sausedo, Grant A. Moen, Isaac J. Lee, Dominic J. Ivan, Tyler D. Krall, Samuel J. Peoples, Anthony Perez, Lucas Tromba, Anh Le, Iraj Khadka, Ryan Petros, Brianna M. Savage, Eleine Salama, Jakline Salama, Joseph W. Ziller, Youngbin Noh, Ming-Yue Lee, Wei Liu, John S. Welch, Pamela A. Marshall, Carl E. Wagner. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. International Journal of Molecular Sciences 2022, 23 (24) , 16213. https://doi.org/10.3390/ijms232416213
    49. Daniel C. Salgueiro, Benjamin K. Chi, Ilia A. Guzei, Pablo García‐Reynaga, Daniel J. Weix. Control of Redox‐Active Ester Reactivity Enables a General Cross‐Electrophile Approach to Access Arylated Strained Rings**. Angewandte Chemie International Edition 2022, 61 (33) https://doi.org/10.1002/anie.202205673
    50. Daniel C. Salgueiro, Benjamin K. Chi, Ilia A. Guzei, Pablo García‐Reynaga, Daniel J. Weix. Control of Redox‐Active Ester Reactivity Enables a General Cross‐Electrophile Approach to Access Arylated Strained Rings**. Angewandte Chemie 2022, 134 (33) https://doi.org/10.1002/ange.202205673
    51. Samridhi Sharma, Ting Shen, Nitin Chitranshi, Veer Gupta, Devaraj Basavarajappa, Soumalya Sarkar, Mehdi Mirzaei, Yuyi You, Wojciech Krezel, Stuart L. Graham, Vivek Gupta. Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement. Molecular Neurobiology 2022, 59 (4) , 2027-2050. https://doi.org/10.1007/s12035-021-02709-y
    52. Govindarajan Thangavelu, Michael C. Zaiken, Fathima A. Mohamed, Ryan Flynn, Jing Du, Stephanie Y. Rhee, Megan J. Riddle, Ethan G. Aguilar, Angela Panoskaltsis-Mortari, Martin E. Sanders, Bruce R. Blazar. Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease. Frontiers in Immunology 2022, 13 https://doi.org/10.3389/fimmu.2022.765319
    53. Peter W. Jurutka, Orsola di Martino, Sabeeha Reshi, Sanchita Mallick, Zhela L. Sabir, Lech J. P. Staniszewski, Ankedo Warda, Emma L. Maiorella, Ani Minasian, Jesse Davidson, Samir J. Ibrahim, San Raban, Dena Haddad, Madleen Khamisi, Stephanie L. Suban, Bradley J. Dawson, Riley Candia, Joseph W. Ziller, Ming-Yue Lee, Chang Liu, Wei Liu, Pamela A. Marshall, John S. Welch, Carl E. Wagner. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB). International Journal of Molecular Sciences 2021, 22 (22) , 12371. https://doi.org/10.3390/ijms222212371
    54. Noriko Suzuki‐Kemuriyama, Akari Abe, Sae Nakane, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima, Dai Nakae. Nonobese mice with nonalcoholic steatohepatitis fed on a choline‐deficient, l ‐amino acid‐defined, high‐fat diet exhibit alterations in signaling pathways. FEBS Open Bio 2021, 11 (11) , 2950-2965. https://doi.org/10.1002/2211-5463.13272
    55. Baixue Li, Shi-Ying Cai, James L. Boyer. The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021, 1867 (5) , 166085. https://doi.org/10.1016/j.bbadis.2021.166085
    56. Chloé Maucort, Audrey Di Giorgio, Stéphane Azoulay, Maria Duca. Differentiation of Cancer Stem Cells by Using Synthetic Small Molecules: Toward New Therapeutic Strategies against Therapy Resistance. ChemMedChem 2021, 16 (1) , 14-29. https://doi.org/10.1002/cmdc.202000251
    57. Nahid Shahabadi, Saba Zendehcheshm, Mohammad Mahdavi, Fatemeh Khademi. Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach. Informatics in Medicine Unlocked 2021, 26 , 100745. https://doi.org/10.1016/j.imu.2021.100745
    58. Ana S. Leal, Lyndsey A. Reich, Jessica A. Moerland, Di Zhang, Karen T. Liby. Potential therapeutic uses of rexinoids. 2021, 141-183. https://doi.org/10.1016/bs.apha.2021.01.004
    59. Xiaozheng Dou, Adam S. Duerfeldt. Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. International Journal of Molecular Sciences 2020, 21 (23) , 9251. https://doi.org/10.3390/ijms21239251
    60. Ana M. Silva, Anna Cederbalk, Daniel Ebner, Elena Di Daniel. Chemical Probes in Cellular Assays for Target Validation and Screening in Neurodegeneration. 2020, 276-319. https://doi.org/10.1039/9781839160745-00276
    61. Frank-Un Hong, Miguel Castro, Klaus Linse. Tumor-specific lytic path “hyperploid progression mediated death”: Resolving side effects through targeting retinoblastoma or p53 mutant. World Journal of Clinical Oncology 2020, 11 (11) , 854-867. https://doi.org/10.5306/wjco.v11.i11.854
    62. Shuofeng Yuan, Jasper F.W. Chan, Kenn K.H. Chik, Chris C.Y. Chan, Jessica O.L. Tsang, Ronghui Liang, Jianli Cao, Kaiming Tang, Lin-Lei Chen, Kun Wen, Jian-Piao Cai, Zi-Wei Ye, Gang Lu, Hin Chu, Dong-Yan Jin, Kwok-Yung Yuen. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacological Research 2020, 159 , 104960. https://doi.org/10.1016/j.phrs.2020.104960
    63. Robert S. Leigh, Bogac L. Kaynak. Vitamin A as a Transcriptional Regulator of Cardiovascular Disease. Hearts 2020, 1 (2) , 126-145. https://doi.org/10.3390/hearts1020013
    64. David R. Chisholm, Andrew Whiting. Design of synthetic retinoids. 2020, 453-491. https://doi.org/10.1016/bs.mie.2020.02.011
    65. K.A. Crawford, B.W. Clark, W.J. Heiger-Bernays, S.I. Karchner, M.E. Hahn, D.E. Nacci, J.J. Schlezinger. Tributyltin disrupts fin development in Fundulus heteroclitus from both PCB-sensitive and resistant populations: Investigations of potential interactions between AHR and PPARγ. Aquatic Toxicology 2020, 218 , 105334. https://doi.org/10.1016/j.aquatox.2019.105334
    66. Jingbo Qin, Jie Liu, Chunxiao Wu, Jianwen Xu, Bowen Tang, Kaiqiang Guo, Xiaohui Chen, Weihao Liu, Tong Wu, Hu Zhou, Meijuan Fang, Zhen Wu. Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35 (1) , 880-896. https://doi.org/10.1080/14756366.2020.1740692
    67. Lariah Edwards, James Watt, Thomas F. Webster, Jennifer J. Schlezinger. Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum. Environmental Health 2019, 18 (1) https://doi.org/10.1186/s12940-019-0486-2
    68. Simone Schierle, Daniel Merk. Therapeutic modulation of retinoid X receptors – SAR and therapeutic potential of RXR ligands and recent patents. Expert Opinion on Therapeutic Patents 2019, 29 (8) , 605-621. https://doi.org/10.1080/13543776.2019.1643322
    69. Wojciech Krężel, Ralph Rühl, Angel R. de Lera. Alternative retinoid X receptor (RXR) ligands. Molecular and Cellular Endocrinology 2019, 491 , 110436. https://doi.org/10.1016/j.mce.2019.04.016
    70. Nathalia Rodrigues de Almeida, Martin Conda‐Sheridan. A review of the molecular design and biological activities of RXR agonists. Medicinal Research Reviews 2019, 39 (4) , 1372-1397. https://doi.org/10.1002/med.21578
    71. Di Zhang, Ana S. Leal, Sarah Carapellucci, Pritika H. Shahani, Jaskaran S. Bhogal, Samir Ibrahim, San Raban, Peter W. Jurutka, Pamela A. Marshall, Michael B. Sporn, Carl E. Wagner, Karen T. Liby. Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention. Cancer Prevention Research 2019, 12 (4) , 211-224. https://doi.org/10.1158/1940-6207.CAPR-18-0317
    72. Claudio Martínez, José A. Souto, Angel R. de Lera. Ligand Design for Modulation of RXR Functions. 2019, 51-72. https://doi.org/10.1007/978-1-4939-9585-1_4
    73. Peter W. Jurutka, Carl E. Wagner. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN. 2019, 95-108. https://doi.org/10.1007/978-1-4939-9585-1_7
    74. Carl E. Wagner, Peter W. Jurutka. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN. 2019, 109-121. https://doi.org/10.1007/978-1-4939-9585-1_8
    75. Yogita Dheer, Nitin Chitranshi, Veer Gupta, Mojdeh Abbasi, Mehdi Mirzaei, Yuyi You, Roger Chung, Stuart L. Graham, Vivek Gupta. Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation. Molecular Neurobiology 2018, 55 (12) , 9043-9056. https://doi.org/10.1007/s12035-018-1041-9
    76. Junwei Chen, Xin Cao, Quanlin An, Yao Zhang, Ke Li, Wenting Yao, Fuchun Shi, Yanfang Pan, Qiong Jia, Wenwen Zhou, Fang Yang, Fuxiang Wei, Ning Wang, Biao Yu. Inhibition of cancer stem cell like cells by a synthetic retinoid. Nature Communications 2018, 9 (1) https://doi.org/10.1038/s41467-018-03877-7
    77. Zoltan Simandi, Attila Horvath, Ixchelt Cuaranta-Monroy, Sascha Sauer, Jean-Francois Deleuze, Laszlo Nagy. RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification. Molecular and Cellular Endocrinology 2018, 471 , 51-62. https://doi.org/10.1016/j.mce.2017.07.033
    78. Bentley J. Hanish, Jennifer F. Hackney Price, Ichiro Kaneko, Ning Ma, Arjan van der Vaart, Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics. Steroids 2018, 135 , 36-49. https://doi.org/10.1016/j.steroids.2018.04.009
    79. Brenda J Mengeling, Michael L Goodson, J David Furlow. RXR Ligands Modulate Thyroid Hormone Signaling Competence in Young Xenopus laevis Tadpoles. Endocrinology 2018, 159 (7) , 2576-2595. https://doi.org/10.1210/en.2018-00172
    80. J. ZHANG, H. WU, S. MA, F. JING, C. YU, L. GAO, J. ZHAO. Transcription Regulators and Hormones Involved in the Development of Brown Fat and White Fat Browning: Transcriptional and Hormonal Control of Brown/Beige Fat Development. Physiological Research 2018, , 347-362. https://doi.org/10.33549/physiolres.933650
    81. V. S. Masyuk, I. V. Mineeva. Synthesis of phenyl analog of retinoic acid methyl ester proceeding from 3-(bromomethyl)but-3-enal diethylacetal. Russian Journal of Organic Chemistry 2017, 53 (11) , 1642-1650. https://doi.org/10.1134/S1070428017110045
    82. Pascal Heitel, Janosch Achenbach, Daniel Moser, Ewgenij Proschak, Daniel Merk. DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators. Bioorganic & Medicinal Chemistry Letters 2017, 27 (5) , 1193-1198. https://doi.org/10.1016/j.bmcl.2017.01.066
    83. Johnny Habchi, Sean Chia, Ryan Limbocker, Benedetta Mannini, Minkoo Ahn, Michele Perni, Oskar Hansson, Paolo Arosio, Janet R. Kumita, Pavan Kumar Challa, Samuel I. A. Cohen, Sara Linse, Christopher M. Dobson, Tuomas P. J. Knowles, Michele Vendruscolo. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease. Proceedings of the National Academy of Sciences 2017, 114 (2) https://doi.org/10.1073/pnas.1615613114
    84. Baoming Nie, Tao Nie, Xiaoyan Hui, Ping Gu, Liufeng Mao, Kuai Li, Ran Yuan, Jiashun Zheng, Haixia Wang, Ke Li, Shibing Tang, Yu Zhang, Tao Xu, Aimin Xu, Donghai Wu, Sheng Ding. Brown Adipogenic Reprogramming Induced by a Small Molecule. Cell Reports 2017, 18 (3) , 624-635. https://doi.org/10.1016/j.celrep.2016.12.062
    85. Martine Cao, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Michael B. Sporn, Karen T. Liby. The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice. Cancer Prevention Research 2016, 9 (1) , 105-114. https://doi.org/10.1158/1940-6207.CAPR-15-0325
    86. Zhiyan Xiao, Susan L. Morris‐Natschke, Kuo‐Hsiung Lee. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Medicinal Research Reviews 2016, 36 (1) , 32-91. https://doi.org/10.1002/med.21377
    87. Cuong V. Nguyen, Kimberly A. Bohjanen. Skin-Directed Therapies in Cutaneous T-Cell Lymphoma. Dermatologic Clinics 2015, 33 (4) , 683-696. https://doi.org/10.1016/j.det.2015.05.004
    88. Xavier C. Giner, David Cotnoir‐White, Sylvie Mader, Daniel Lévesque. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer‐specific bioluminescence resonance energy transfer‐based sensors. The FASEB Journal 2015, 29 (10) , 4256-4267. https://doi.org/10.1096/fj.14-259804
    89. Ralph Rühl, Agnieszka Krzyżosiak, Anna Niewiadomska-Cimicka, Natacha Rochel, Lajos Szeles, Belén Vaz, Marta Wietrzych-Schindler, Susana Álvarez, Monika Szklenar, Laszlo Nagy, Angel R. de Lera, Wojciech Krężel, . 9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice. PLOS Genetics 2015, 11 (6) , e1005213. https://doi.org/10.1371/journal.pgen.1005213
    90. Shuo Wei, Shingo Kozono, Lev Kats, Morris Nechama, Wenzong Li, Jlenia Guarnerio, Manli Luo, Mi-Hyeon You, Yandan Yao, Asami Kondo, Hai Hu, Gunes Bozkurt, Nathan J Moerke, Shugeng Cao, Markus Reschke, Chun-Hau Chen, Eduardo M Rego, Francesco Lo-Coco, Lewis C Cantley, Tae Ho Lee, Hao Wu, Yan Zhang, Pier Paolo Pandolfi, Xiao Zhen Zhou, Kun Ping Lu. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine 2015, 21 (5) , 457-466. https://doi.org/10.1038/nm.3839
    91. Marco‐Antonio Mendoza‐Parra, William Bourguet, Angel R. de Lera, Hinrich Gronemeyer. Retinoid Receptor‐Selective Modulators. 2015, 165-192. https://doi.org/10.1002/9781118628003.ch9
    92. Marcia I. Dawson, Zebin Xia. Use of Retinoid Receptor Ligands to Identify Other Nuclear Receptor Ligands. 2015, 193-271. https://doi.org/10.1002/9781118628003.ch10
    93. Pamela A. Marshall, Peter W. Jurutka, Carl E. Wagner, Arjan van der Vaart, Ichiro Kaneko, Pedro I. Chavez, Ning Ma, Jaskaran S. Bhogal, Pritika Shahani, Johnathon C. Swierski, Mairi MacNeill. Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles. Pharmacology Research & Perspectives 2015, 3 (2) https://doi.org/10.1002/prp2.122
    94. Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, Francesca Pagano, Laura Cicconi, Cécile Rochette-Egly, Francesco Lo-Coco, Paolo Ascenzi, Clara Nervi. Retinoic acid receptors: From molecular mechanisms to cancer therapy. Molecular Aspects of Medicine 2015, 41 , 1-115. https://doi.org/10.1016/j.mam.2014.12.003
    95. David P. Marciano, Dana S. Kuruvilla, Bruce D. Pascal, Patrick R. Griffin. Identification of Bexarotene as a PPAR γ Antagonist with HDX. PPAR Research 2015, 2015 , 1-6. https://doi.org/10.1155/2015/254560
    96. Leon M. Tai, Kevin P. Koster, Jia Luo, Sue H. Lee, Yue-ting Wang, Nicole C. Collins, Manel Ben Aissa, Gregory R.J. Thatcher, Mary Jo LaDu. Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo. Journal of Biological Chemistry 2014, 289 (44) , 30538-30555. https://doi.org/10.1074/jbc.M114.600833
    97. Valerie Bomben, Jerrah Holth, John Reed, Paige Cramer, Gary Landreth, Jeffrey Noebels. Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy. Neurobiology of Aging 2014, 35 (9) , 2091-2095. https://doi.org/10.1016/j.neurobiolaging.2014.03.029
    98. Chien-Hsun Chen, Pei-Hsin Chou, Masanobu Kawanishi, Takashi Yagi. Occurrence of xenobiotic ligands for retinoid X receptors and thyroid hormone receptors in the aquatic environment of Taiwan. Marine Pollution Bulletin 2014, 85 (2) , 613-618. https://doi.org/10.1016/j.marpolbul.2014.01.025
    99. John G. Moffat, Joachim Rudolph, David Bailey. Phenotypic screening in cancer drug discovery — past, present and future. Nature Reviews Drug Discovery 2014, 13 (8) , 588-602. https://doi.org/10.1038/nrd4366
    100. Bence Daniel, Gergely Nagy, Nasun Hah, Attila Horvath, Zsolt Czimmerer, Szilard Poliska, Tibor Gyuris, Jiri Keirsse, Conny Gysemans, Jo A. Van Ginderachter, Balint L. Balint, Ronald M. Evans, Endre Barta, Laszlo Nagy. The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages. Genes & Development 2014, 28 (14) , 1562-1577. https://doi.org/10.1101/gad.242685.114
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect